If lumps persist or spread, contact your provider
In STEP 1, published in the New England Journal of Medicine, 1,961 adults with obesity or overweight plus a coexisting condition and without diabetes were randomized to 68 weeks of once-weekly semaglutide 2.4 mg or placebo
Current anti-obesity pharmacotherapy includes 5 FDA-approved medications: orlistat, phentermine-topiramate, naltrexone-bupropion, liraglutide, and semaglutide (Table 2), as well as phentermine, which is approved only for short term use
Orem, UT June 9, 2026 DietsMD.com, an online medical weight loss platform specializing in doctor-guided GLP-1 treatment programs, today announced the expansion of its telehealth weight loss services designed to help eligible patients explore semaglutide, tirzepatide, and emerging oral GLP-1 treatment options through a streamlined online experience
Clinical reviews in obesity medicine literature also note that Obesity Management Medications, including GLP 1 receptor agonists, may be considered in select post surgical patients for weight recurrence or less than expected clinical response, but only with careful medical supervision and ongoing nutritional surveillance
